Evaluation of CCR5 Expression on NK Cells in Iranian Patients With Occult Hepatitis B Infection-Reference-Cited by-同舟云学术

Evaluation of CCR5 Expression on NK Cells in Iranian Patients With Occult Hepatitis B Infection

Published:2010-12 Issue:12 Volume:41 Page:735-738
ISSN:0007-5027
Container-title:Laboratory Medicine
language:en
Short-container-title:Lab Med

Author:

Arababadi Mohammad Kazemi,Pourfathollah Ali Akbar,Jafarzadeh Abdollah,Hassanshahi Gholamhossein,Mohit Maryam,Hajghani Masomeh,Ahmadabadi Behzad Nasiri,Kennedy Derek

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Link

http://academic.oup.com/labmed/article-pdf/41/12/735/8321985/labmed41-0735.pdf

Reference27 articles.

1. Arababadi MK Hassanshahi G Yousefi H . HBV-DNA in hemodialysis patients infected by HCV. Saudi J Kidney Dis Transpl. 2009;20:398–401.

2. Peripheral Blood CD8+T Cells CCR5 Expression and Its Δ32 Mutation in Iranian Patients with Occult Hepatitis B Infections

3. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients

4. No Detected Hepatitis B Virus-DNA in Thalassemic Patients Infected by Hepatitis C Virus in Kerman Province of Iran

5. Jafarzadeh A Arababadi MK Mirzaee M Occult hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Acta Med Iran. 2008;46:27–32.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innate immunity and early liver inflammation;Frontiers in Immunology;2023-05-02

2. Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease;International Journal of Molecular Sciences;2020-02-21

3. Study of CCR5-59353C/T Polymorphism in the Iranian Patients With Chronic Hepatitis B Virus Infection;Middle East Journal of Rehabilitation and Health;2017-07-31

4. CCR5 Plays Important Roles in Hepatitis B Infection;Viral Immunology;2014-02

5. NK cells in hepatitis B virus infection: a potent target for immunotherapy;Archives of Virology;2014-01-21